A new study from Zagazig University links PON1 gene variants and reduced antioxidant enzyme levels to nephrotic syndrome in Egyptian children.

With funding from charity Kidney Research UK, Dr Carl May from Bristol Medical School and his team have identified a new treatment pathway for patients with non-genetic (idiopathic) nephrotic syndrome ...

Steroid-resistant nephrotic syndrome (SRNS) is a disease characterized by hypoalbuminemia, proteinuria, edema and hyperlipidemia, and a cause of chronic kidney disease in the pediatric population.

One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome. However, what about patients ...

What Is Gazyva and What Is the Approval For? The FDA has approved Gazyva (obinutuzumab) for adults and children aged 2 years or older who have a kidney disorder called idiopathic nephrotic syndrome.

Primary nephrotic syndrome in adults is characterized by severe proteinuria and hypoalbuminemia. This was the first clinical trial to test rituximab in adult-onset frequently relapsing nephrotic ...